Telmisartan Treatment Ameliorates Memory Deficits in Streptozotocin-Induced Diabetic Mice via Attenuating Cerebral Amyloidosis

• Main Authors: Guan Tao Du (Author), Meng Hu (Author), Zhen Lin Mei (Author), Chao Wang (Author), Guang Jun Liu (Author), Mei Hu (Author), Yan Long (Author), Ming Xing Miao (Author), Jia Chang Li (Author), Hao Hong (Author)
• Format: Book
• Published: Elsevier, 2014-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Telmisartan, an angiotensin II type 1-receptor blocker (ARBs), has been reported to exert beneficial effects on the central nervous system (CNS). However, the effect of telmisartan on cognitive impairment associated with type 1 diabetes is not well known. Here, we examined the possibility that telmi...